Literature DB >> 6812681

Managing hyperlipidaemias.

B M Buckley, A M Bold.   

Abstract

Mesh：

Year:  1982        PMID： 6812681     DOI： 10.1136/bmj.285.6351.1293

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

Review 1.  Classification of hyperlipidaemias and hyperlipoproteinaemias.

Authors:  J L Beaumont; L A Carlson; G R Cooper; Z Fejfar; D S Fredrickson; T Strasser
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

2.  Probucol and the QT interval.

Authors:  G Troendle; J Guerigian; S Sobel; M Johnson
Journal:  Lancet       Date:  1982-05-22       Impact factor: 79.321

3.  Probucol and the QT interval.

Authors:  B L Martz
Journal:  Lancet       Date:  1982-06-12       Impact factor: 79.321

4.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

5.  Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.

Authors:  N E Miller; F Hammett; S Saltissi; S Rao; H van Zeller; J Coltart; B Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30
  5 in total
  3 in total

1.  How soon after myocardial infarction should plasma lipid values be assessed?

Authors:  R E Ryder; T M Hayes; I P Mulligan; J C Kingswood; S Williams; D R Owens
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

2.  Beta-blocker induced changes in the cholesterol: high-density lipoprotein cholesterol ratio and risk of coronary heart disease.

Authors:  B G Woodcock; N Rietbrock
Journal:  Klin Wochenschr       Date:  1984-09-17

3.  Serum lipid profile in patients with acute myocardial infarction.

Authors:  P K Nigam; V S Narain; M Hasan
Journal:  Indian J Clin Biochem       Date:  2004-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.